- Empiric or Confirmed treatment of severe fungal infections
- RESTRICTED TO INFECTIOUS DISEASE / ONCOLOGY
VIAL SIZE | STERILE WATER for INJECTION REQUIRED | FINAL CONCENTRATION |
50 mg | 12 mL -shake vigorously 30 seconds | 4 mg/mL |
- Filter through a 5 micron filter prior to dilution -use 1 filter for each vial of drug
- Protect from light
- Reconstituted vial stable 24 hours refrigerated
- Diluted in D5W to 0.2 mg/mL stable 11 days refrigerated, 24 hours at room temperature
- Diluted in D5W to 2 mg/mL stable 14 days refrigerated, 24 hours at room temperature
-Solutions Compatible: Dextrose solution up to D25W
-DO NOT mix with other drugs
-Incompatible: saline solutions
(For approved routes of administration by nursing personnel, refer to Policy for the Administration of Intravenous Medications.)
SC | NO |
IM | NO |
IV Direct | NO |
IV Intermittent Infusion |
YES Large volume pump: Usual dilution: 0.2-2 mg/mL |
IV Continuous Infusion | NO |
(For neonatal dosages, refer to Neonatal IV Drug Manual.)
Adult / Pediatric (greater than 1 month):
- Initial: 3 - 5 mg/kg/day
- Doses of 10 mg/kg/day have been use in patients with documented Aspergillus infection
- Extravasation causes severe chemical irritation. If extravasation occurs, see Treatment of Infiltrated Vesicant or Irritant Drugs Guidelines on CHEOnet.
- Transient decreases in renal function: hypokalemia, nephrotoxicity (azotemia, increased serum creatinine, renal tubular acidosis)
- Diarrhea, nausea, vomiting
- Arrhythmias
- Anaphylaxis
- CNS: headache, dizziness, fever/chills
- Elevated liver enzymes (AST, ALT, alkaline phosphatase)
- Monitor hepatic and renal function tests, CBC, electrolytes (especially magnesium and potassium)
- Dose adjustment may be required with renal dysfunction
- DO NOT administer through a line with an in-line filter less than 1 micron
- Flush line with D5W prior to infusion
- Consider sodium loading to minimize the nephrotoxic risk
- Patient must be euvolemic with a normal serum sodium
- Contraindication - significant cardiac, renal or respiratory compromise
- Procedure - infuse sodium chloride 0.9% 10 mL/kg (1.5 mmol Na/Kg) IV over 60 minutes prior to Amphotericin B Liposomal infusions
- Flush IV lines with dextrose solution prior to administration of Amphotericin B Liposomal due to incompatibility with saline containing solutions
- Continue sodium loading for the duration of Amphotericin B Liposomal therapy